Department of Neurosurgery, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
Department of Neurosurgery and Neurooncology, 1St Faculty of Medicine, Charles University, Military University Hospital, U Vojenske Nemocnice, 1200, Prague 6, Czech Republic.
Acta Neurochir (Wien). 2022 Jan;164(1):61-77. doi: 10.1007/s00701-021-05054-0. Epub 2021 Dec 2.
To examine published data and assess evidence relating to safety and efficacy of surgical management of symptomatic pineal cysts without hydrocephalus (nhSPC), we performed a systematic review of the literature and meta-analysis.
Following the PRISMA guidelines, we searched Pubmed and SCOPUS for all reports with the query 'Pineal Cyst' AND 'Surgery' as of March 2021, without constraints on study design, publication year or status (PROSPERO_CRD:42,021,242,517). Assessment of 1537 hits identified 26 reports that met inclusion and exclusion criteria.
All 26 input studies were either case reports or single-centre retrospective cohorts. The majority of outcome data were derived from routine physician-recorded notes. A total of 294 patients with surgically managed nhSPC were identified. Demographics: Mean age was 29 (range: 4-63) with 77% females. Mean cyst size was 15 mm (5-35). Supracerebellar-infratentorial approach was adopted in 90% of cases, occipital-transtentorial in 9%, and was not reported in 1%. Most patients were managed by cyst resection (96%), and the remainder by fenestration. Mean post-operative follow-up was 35 months (0-228).
Headache was the commonest symptom (87%), followed by visual (54%), nausea/vomit (34%) and vertigo/dizziness (31%). Other symptoms included focal neurology (25%), sleep disturbance (17%), cognitive impairment (16%), loss of consciousness (11%), gait disturbance (11%), fatigue (10%), 'psychiatric' (2%) and seizures (1%). Mean number of symptoms reported at presentation was 3 (0-9).
Improvement rate was 93% (to minimise reporting bias only consecutive cases from cohort studies were considered, N = 280) and was independent of presentation. Predictors of better outcomes were large cyst size (OR = 5.76; 95% CI: 1.74-19.02) and resection over fenestration (OR = 12.64; 3.07-52.01). Age predicted worse outcomes (OR = 0.95; 0.91-0.99). Overall complication rate was 17% and this was independent of any patient characteristics. Complications with long-term consequences occurred in 10 cases (3.6%): visual disturbance (3), chronic incisional pain (2), sensory disturbance (1), fatigue (1), cervicalgia (1), cerebellar stroke (1) and mortality due to myocardial infarction (1).
Although the results support the role of surgery in the management of nhSPCs, they have to be interpreted with a great deal of caution as the current evidence is limited, consisting only of case reports and retrospective surgical series. Inherent to such studies are inhomogeneity and incompleteness of data, selection bias and bias related to assessment of outcome carried out by the treating surgeon in the majority of cases. Prospective studies with patient-reported and objective outcome assessment are needed to provide higher level of evidence.
为了检查与无症状性松果体囊肿(无脑积水,nhSPC)的手术治疗安全性和疗效相关的已发表数据并评估证据,我们对文献进行了系统回顾和荟萃分析。
根据 PRISMA 指南,我们在 2021 年 3 月前在 Pubmed 和 SCOPUS 上搜索了所有带有“松果体囊肿”和“手术”查询词的报告,研究设计、出版年份或状态不受限制(PROSPERO_CRD:42,021,242,517)。对 1537 个命中结果进行评估,确定了 26 项符合纳入和排除标准的报告。
所有 26 项输入研究均为病例报告或单中心回顾性队列研究。大多数结局数据来自常规医生记录的笔记。共确定了 294 例接受手术治疗的 nhSPC 患者。人口统计学:平均年龄为 29 岁(范围:4-63 岁),女性占 77%。平均囊肿大小为 15 毫米(5-35 毫米)。90%的病例采用了幕上小脑幕下入路,9%采用了枕骨经天幕入路,1%未报告。大多数患者接受了囊肿切除术(96%),其余患者接受了开窗术。平均术后随访 35 个月(0-228 个月)。
头痛是最常见的症状(87%),其次是视觉症状(54%)、恶心/呕吐(34%)和眩晕/头晕(31%)。其他症状包括局灶性神经功能障碍(25%)、睡眠障碍(17%)、认知障碍(16%)、意识丧失(11%)、步态障碍(11%)、疲劳(10%)、“精神”(2%)和癫痫(1%)。就诊时报告的平均症状数为 3 个(0-9 个)。
改善率为 93%(为了尽量减少报告偏倚,仅考虑连续病例的队列研究,N=280),且与表现无关。更好结局的预测因素是大囊肿大小(OR=5.76;95%CI:1.74-19.02)和切除术优于开窗术(OR=12.64;3.07-52.01)。年龄预测结局较差(OR=0.95;0.91-0.99)。总体并发症发生率为 17%,且与任何患者特征无关。有 10 例(3.6%)发生长期后果的并发症:视力障碍(3 例)、慢性切口疼痛(2 例)、感觉障碍(1 例)、疲劳(1 例)、颈痛(1 例)、小脑卒中(1 例)和心肌梗死导致的死亡(1 例)。
尽管结果支持手术治疗 nhSPC 的作用,但由于目前的证据仅限于病例报告和回顾性手术系列,因此必须非常谨慎地解释。此类研究存在异质性和数据不完整性、选择偏倚以及在大多数情况下由治疗医生进行结局评估的偏倚。需要前瞻性研究,以患者报告和客观结局评估来提供更高水平的证据。